Medicare Rights Center, Author at Medicare Rights Center

Medicare Rights Center’s Annual Awards Dinner

Medicare Rights Center February 14, 2018

Over 300 people attended the Medicare Rights Center’s 2017 Annual Awards Dinner in New York City on October
16. Kirk Adams, executive director of the Healthcare Education Project (HEP), was honored at the event along with
HEP Co-Chairs George Gresham, president, 1199SEIU United Healthcare Workers East, and Kenneth E. Raske,
president, Greater New York Hospital Association. HEP is a a unique labor-management alliance that works to protect
and expand access to quality, affordable health care for all New Yorkers. Nancy Richardson, a Medicare Rights
helpline volunteer, was also recognized for her years of dedicated service.

Spotlight on the Federal Policy Team

Medicare Rights Center June 9, 2017

The Medicare Rights’ federal policy team’s work varies day to day, but their overall strategy leads to one goal: to protect and strengthen Medicare for the 56 million individuals who depend on the program today—and the many millions more who are counting on it for the years to come.

35 Organizations Join Together to Provide Recommendations to CMS on the “Welcome to Medicare” Package

Medicare Rights Center May 11, 2017

The Medicare Rights Center and over 30 other national and state organizations, including the Blue Cross Blue Shield Association and

Prescription Drug Pricing Expert Presents at Medicare Rights

Medicare Rights Center April 7, 2016

Peter Bach, MD, MAPP, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, was the guest speaker on “The Future of Drug Pricing” at the Medicare Rights Center’s Policy Breakfast on April 5.

Dr. Bach, a physician, epidemiologist, researcher, and healthcare policy expert whose work focuses on the cost and value of anticancer drugs, is an ardent supporter of value-based pricing for prescription drugs and favors the Centers for Medicare and Medicaid Services’ (CMS) recently announced proposal to test value-based payment strategies for medications covered under Medicare Part B.